Larazotide Acetate
December 18, 2023Promising
5/10
Purrptide digest
Larazotide Acetate tightens up the junctions between your gut cells — literally reducing the gaps that let undigested gluten fragments slip into your bloodstream. It's been through multiple Phase 3 trials specifically for celiac disease, making it one of the more clinically advanced peptides on this entire list. It doesn't cure celiac disease or replace a gluten-free diet — it's positioned as a safety net for accidental gluten exposure, which is most of real life.
What this means for you
🏃
If you care about weight/health
If you manage celiac disease, this is the peptide closest to actually reaching the market as a real safety-net treatment.
🩺
If you're a clinician
Multiple completed Phase 3 trials make this one of the most clinically mature peptides on this list. Worth tracking its approval status.
🔬
If you're a researcher
Tight junction modulation as a therapeutic target for autoimmune gut conditions extends well beyond just celiac applications.
💸
If you follow biotech
Phase 3 data in hand for a real unmet need. This is one of the more investable peptides on the list if it clears the finish line.
LE
Leffler et al.
Innovate Biopharmaceuticals
For the nerds
Larazotide acetate for persistent symptoms of celiac disease
Gastroenterology · DOI: 10.1053/j.gastro.2012.04.045
Read full paper on PubMed →